These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2804345)

  • 1. Detection of factor X activation in humans.
    Bauer KA; Kass BL; ten Cate H; Bednarek MA; Hawiger JJ; Rosenberg RD
    Blood; 1989 Nov; 74(6):2007-15. PubMed ID: 2804345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo.
    Bauer KA; Mannucci PM; Gringeri A; Tradati F; Barzegar S; Kass BL; ten Cate H; Kestin AS; Brettler DB; Rosenberg RD
    Blood; 1992 Apr; 79(8):2039-47. PubMed ID: 1562731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of protein C activation in humans.
    Bauer KA; Kass BL; Beeler DL; Rosenberg RD
    J Clin Invest; 1984 Dec; 74(6):2033-41. PubMed ID: 6549015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the initiation of coagulation by factor VII.
    Nemerson Y
    Haemostasis; 1983; 13(3):150-5. PubMed ID: 6350119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An alternative extrinsic pathway of human blood coagulation.
    Marlar RA; Kleiss AJ; Griffin JH
    Blood; 1982 Dec; 60(6):1353-8. PubMed ID: 7139124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated factor IX-antithrombin III complexes in human blood: quantification by an enzyme-linked differential antibody immunoassay and determination of the in vivo half-life.
    Takahashi I; Kato K; Sugiura I; Takamatsu J; Kamiya T; Saito H
    J Lab Clin Med; 1991 Oct; 118(4):317-25. PubMed ID: 1940573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa.
    van 't Veer C; Golden NJ; Mann KG
    Blood; 2000 Feb; 95(4):1330-5. PubMed ID: 10666207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of plasma factor VIIa levels in humans.
    Eichinger S; Mannucci PM; Tradati F; Arbini AA; Rosenberg RD; Bauer KA
    Blood; 1995 Oct; 86(8):3021-5. PubMed ID: 7579395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.
    Repke D; Gemmell CH; Guha A; Turitto VT; Broze GJ; Nemerson Y
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7623-7. PubMed ID: 2120704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of basal levels of factor VIIa in hemophilia A and B patients.
    Wildgoose P; Nemerson Y; Hansen LL; Nielsen FE; Glazer S; Hedner U
    Blood; 1992 Jul; 80(1):25-8. PubMed ID: 1611090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas.
    Pineo GF; Regoeczi E; Hatton MW; Brain MC
    J Lab Clin Med; 1973 Aug; 82(2):255-66. PubMed ID: 4352814
    [No Abstract]   [Full Text] [Related]  

  • 12. The factor VIII-independent activation of factor X by factors IXa and VII in plasma.
    Ofosu F; Blajchman MA; Modi G; Hirsh J
    Thromb Res; 1981 Jan 1-15; 21(1-2):23-33. PubMed ID: 6785896
    [No Abstract]   [Full Text] [Related]  

  • 13. No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate.
    Mannucci PM; Bauer KA; Gringeri A; Barzegar S; Santagostino E; Tradati FC; Rosenberg RD
    Br J Haematol; 1991 Dec; 79(4):606-11. PubMed ID: 1772782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation activity of surface activated plasma in vivo.
    Swedenborg J; Kourias E; Olsson P
    Thromb Res; 1979; 16(1-2):231-7. PubMed ID: 505418
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of a radioimmunoassay for quantitating prethrombin 2 in human plasma.
    Conway EM; Lau HK; Bauer KA; Rosenberg RD
    J Lab Clin Med; 1987 Nov; 110(5):567-75. PubMed ID: 3668358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the coagulation factors from V through XIII].
    Yoshida K; Tagawa N
    Nihon Rinsho; 1973 Apr; 31(4):755-64. PubMed ID: 4580392
    [No Abstract]   [Full Text] [Related]  

  • 17. Initiation of the extrinsic pathway of coagulation by human and rabbit alveolar macrophages: a kinetic study.
    McGee MP; Wallin R; Wheeler FB; Rothberger H
    Blood; 1989 Oct; 74(5):1583-90. PubMed ID: 2790188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
    Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional difference between intrinsic and extrinsic coagulation pathways. Kinetics of factor X activation on human monocytes and alveolar macrophages.
    McGee MP; Li LC
    J Biol Chem; 1991 May; 266(13):8079-85. PubMed ID: 1902470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
    Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
    J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.